Kwangdong Phar (009290.KS) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · South Korea · ISIN KR7009290008

Price
6,390.00 KRW
Market cap
317.60 bn KRW
P/E (2025)
–
P/S (2025)
0.19
Dividend yield
1.56 %
Net margin
1.26 %
Return on equity (ROE)
2.95 %
Return on assets (ROA)
1.59 %

Kwangdong Phar financials

Fiscal year20242025
Revenue1.64 tn KRW1.66 tn KRW
Gross profit299.30 bn KRW301.18 bn KRW
Operating income30.10 bn KRW31.05 bn KRW
EBIT67.60 bn KRW41.99 bn KRW
Net income40.48 bn KRW20.97 bn KRW

Full history since 2011, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Kwangdong Phar

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti-inflammatory agents, neuropsychiatric solvent, digestive organ agent, antibiotic, and vitamins. The company also offers supplements for low content vitamin, mineral or vital energy substance and quasi drugs. In addition, it provides blackberry, ginger lonicerae flos, vita gold, and red ginseng gold drinks, as well as offers water, mixed drinks, tea drinks, and other drinks; and traditional health foods. The company offers its products through operation of TV, radio, and print advertising. Kwang Dong Pharmaceutical Co., Ltd. was founded in 1963 and is based in Seoul, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.